We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
(+2.2%)
Cap. Flow
-$488M
Cap. Flow
% of AUM
-0.46%
Top 10 Holdings %
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$101M |
| 2 |
GE Vernova
GEV
|
+$75.4M |
| 3 |
CRH
CRH
|
+$48.5M |
| 4 |
CrowdStrike
CRWD
|
+$45.8M |
| 5 |
Dell
DELL
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$180M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$121M |
| 3 |
GE Aerospace
GE
|
+$59.1M |
| 4 |
UnitedHealth
UNH
|
+$46.6M |
| 5 |
NVIDIA
NVDA
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.98% |
| 2 | Financials | 12.55% |
| 3 | Healthcare | 11.48% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 8.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Pearson
PSO
$9.9B
| $144K | ﹤0.01% |
11,518
+1,281
| +13% | +$15.8K |
|
3152
Candel Therapeutics
CADL
$776M
| $143K | ﹤0.01% |
+22,985
| New | +$173K |
|
|
RAPT
3153
DELISTED
RAPT Therapeutics
RAPT
| $142K | ﹤0.01% |
5,814
+373
| +7% | +$17.2K |
|
3154
Nerdy
NRDY
$96.1M
| $142K | ﹤0.01% |
84,739
+8,834
| +12% | +$19.4K |
|
3155
Townsquare Media
TSQ
$118M
| $139K | ﹤0.01% |
12,660
+2,481
| +24% | +$28.6K |
|
3156
Lifecore Biomedical
LFCR
$190M
| $138K | ﹤0.01% |
26,899
+25,378
| +1,669% | +$150K |
|
3157
iShares Russell 2000 Value ETF
IWN
$14.6B
| $138K | ﹤0.01% |
905
-4,129
| -82% | -$631K |
|
|
KPN
3158
DELISTED
ROYAL KPN NV ADS (EA REPTG 1 ORD SH)
KPN
| $138K | ﹤0.01% |
36,402
+9,491
| +35% | +$35.9K |
|
3159
Q32 Bio
QTTB
$464M
| $137K | ﹤0.01% |
7,658
+7,593
| +11,682% | +$182K |
|
|
LNKB
3160
DELISTED
LINKBANCORP
LNKB
| $137K | ﹤0.01% |
+22,401
| New | +$144K |
|
|
RGLS
3161
DELISTED
Regulus Therapeutics
RGLS
| $136K | ﹤0.01% |
+76,472
| New | +$177K |
|
3162
InnovAge Holding
INNV
$1.52B
| $136K | ﹤0.01% |
27,503
+1,793
| +7% | +$7.79K |
|
3163
Franco-Nevada
FNV
$46B
| $136K | ﹤0.01% |
1,150
-237
| -17% | -$28.8K |
|
3164
Harvard Bioscience
HBIO
$29.2M
| $136K | ﹤0.01% |
4,775
+951
| +25% | +$33.4K |
|
3165
Bank7 Corp
BSVN
$481M
| $136K | ﹤0.01% |
4,336
-249
| -5% | -$7.2K |
|
3166
Waldencast
WALD
$178M
| $134K | ﹤0.01% |
37,408
-964
| -3% | -$4.72K |
|
3167
Eastern Company
EML
$150M
| $134K | ﹤0.01% |
+5,261
| New | +$153K |
|
3168
Century Therapeutics
IPSC
$361M
| $134K | ﹤0.01% |
52,466
+18,828
| +56% | +$59.5K |
|
3169
Perma-Fix Environmental Services
PESI
$383M
| $134K | ﹤0.01% |
+13,200
| New | +$146K |
|
3170
Geospace Technologies
GEOS
$75.7M
| $133K | ﹤0.01% |
14,824
+14,224
| +2,371% | +$160K |
|
3171
Kodiak Sciences
KOD
$2.84B
| $133K | ﹤0.01% |
56,511
+586
| +1% | +$1.99K |
|
|
GPGI
3172
GPGI Inc
GPGI
$4.35B
| $133K | ﹤0.01% |
23,503
+3,464
| +17% | +$19.1K |
|
3173
iShares MSCI Netherlands ETF
EWN
$637M
| $133K | ﹤0.01% |
2,638
| – | – |
|
3174
Traeger
COOK
$172M
| $132K | ﹤0.01% |
1,103
+15
| +1% | +$1.73K |
|
3175
Lineage Cell Therapeutics
LCTX
$274M
| $132K | ﹤0.01% |
132,491
+17,411
| +15% | +$19.2K |
|
Similar funds
VAM
RhumbLine Advisers's Q2 2024 Portfolio in Review
As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
- RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
- RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
- RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
- RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
- RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
- RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.
Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.